Literature DB >> 9815894

Loss and gain of distinct regions of chromosome 1q in primary breast cancer.

I Bièche1, M H Champème, R Lidereau.   

Abstract

Alterations of the long arm of chromosome 1 are the most frequent cytogenetic abnormalities found in human breast carcinoma. We examined genetic alterations on chromosome 1q in 124 human breast tumors, using restriction fragment length polymorphism markers mapping to the long arm (13 markers) and short arm (4 markers). Imbalance of heterozygosity at one or more loci on the long arm was observed in 80 (65%) of the 124 tumors. Among these 80 tumor DNAs, 38 showed an allele gain, 16 a loss of heterozygosity, and 1 both allele gain and loss of heterozygosity at each locus on the long arm, indicating that 55 tumor DNAs had a gain and/or loss of the entire long arm of chromosome 1. Detailed alteration mapping of the other 25 tumors showing partial alterations of chromosome 1q identified two distinct altered regions: a smallest common deleted region at 1q21-31 and a smallest common overrepresented region at 1q41-q44. The results suggest that both oncogenes and tumor suppressor genes are present on chromosome 1q and are associated with breast tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9815894

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  14 in total

1.  Expression of the novel human gene, UBE2Q1, in breast tumors.

Authors:  Atefeh Seghatoleslam; Mohsen Nikseresht; Sayed Mohammad Shafiee; Ahmad Monabati; Mohammad Mehdi Namavari; Abdolrassul Talei; Akbar Safaei; Ali Akbar Owji
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

2.  Specific chromosome 1 breaks induced by human cytomegalovirus.

Authors:  E A Fortunato; M L Dell'Aquila; D H Spector
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

4.  Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays.

Authors:  Emilia Wiechec; Jens Overgaard; Eigil Kjeldsen; Lise Lotte Hansen
Journal:  Cell Oncol (Dordr)       Date:  2012-12-18       Impact factor: 6.730

Review 5.  The story of human cytomegalovirus and cancer: increasing evidence and open questions.

Authors:  Martin Michaelis; Hans W Doerr; Jindrich Cinatl
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

6.  Investigation of TXNIP (thioredoxin-interacting protein) and TRX (thioredoxin) genes for growth-related traits in pigs.

Authors:  Mei Yu; Becky Geiger; Nader Deeb; Max F Rothschild
Journal:  Mamm Genome       Date:  2007-04-04       Impact factor: 3.224

7.  AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines.

Authors:  Lee-Jun C Wong; Pu Dai; Jyh-Feng Lu; Mary Ann Lou; Robert Clarke; Viktor Nazarov
Journal:  BMC Cancer       Date:  2006-05-02       Impact factor: 4.430

8.  The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.

Authors:  Aijin Wang; Stacey Arantes; Leqin Yan; Kaoru Kiguchi; Mark J McArthur; Aysegul Sahin; Howard D Thames; C Marcelo Aldaz; Michael C Macleod
Journal:  BMC Cancer       Date:  2008-09-22       Impact factor: 4.430

9.  Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.

Authors:  A Forus; J M Berner; L A Meza-Zepeda; G Saeter; D Mischke; O Fodstad; O Myklebost
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

10.  Breast tumors with elevated expression of 1q candidate genes confer poor clinical outcome and sensitivity to Ras/PI3K inhibition.

Authors:  Muthulakshmi Muthuswami; Vignesh Ramesh; Saikat Banerjee; Soundara Viveka Thangaraj; Jayaprakash Periasamy; Divya Bhaskar Rao; Georgina D Barnabas; Swetha Raghavan; Kumaresan Ganesan
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.